Article
Novel compound heterozygous LRBA deletions in a 6-month-old with neonatal diabetes.
Diabetes research and clinical practice - 1 May 2021
Sanyoura May, Lundgrin Erika L, Subramanian Hari Prasanna, Yu Min, Sodadasi Priscilla, Greeley Siri Atma W, MacLeish Sarah, Del Gaudio Daniela
Abstract excerpt
We report a 6-month-old boy with antibody-positive insulin-dependent diabetes mellitus. Sequencing identified compound heterozygous deletions of exon 5 and exons 36-37 in LRBA. At three years, he has yet to exhibit any other immune symptoms. Genetic testing of LRBA is warranted in patients with neonatal diabetes, even without immune dysregulation.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
